Tenax Therapeutics (TENX) Depreciation and Depletion (2011 - 2024)
Tenax Therapeutics (TENX) reported Depreciation and Depletion of $1000.0 for Q2 2024, little changed on a YoY basis from $1000.0 in Q3 2023, and up 11.73% sequentially from $895.0 in Q1 2024.
Tenax Therapeutics (TENX) Depreciation and Depletion (2011 - 2024) Analysis & Trends
Tenax Therapeutics (TENX) has 14 years of Depreciation and Depletion data on file, last reported at $1000.0 in Q2 2024.
- For the quarter ending Q2 2024, Depreciation and Depletion changed 0.0% year-over-year to $1000.0; the trailing twelve-month figure through Sep 2024 stood at $6565.0 (up 54.91% YoY), and the FY2023 full-year result was $7570.0, up 47.19% from the prior year.
- Depreciation and Depletion rose to $1000.0 in Q2 2024, from $895.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $4670.0 in Q4 2023 to a low of $895.0 in Q1 2023.
- A 5-year average of $1274.9 and a median of $1038.5 in 2020 frame the typical range for Depreciation and Depletion.
- Peak annual rise in Depreciation and Depletion reached 247.73% in 2023, while the deepest fall reached 33.85% in 2023.
- Tracing TENX's Depreciation and Depletion over 5 years: stood at $1077.0 in 2020, then rose by 3.62% to $1116.0 in 2021, then rose by 20.34% to $1343.0 in 2022, then soared by 247.73% to $4670.0 in 2023, then tumbled by 78.59% to $1000.0 in 2024.
- Business Quant data shows TENX's Depreciation and Depletion at $1000.0 in Q2 2024, $895.0 in Q1 2024, and $4670.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Tenax Therapeutics | 67,856.40 | 67,856.40 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | 895.00 |
| Mar 31, 2024 | 895.00 |
| Dec 31, 2023 | 4,670.00 |
| Dec 31, 2023 | 4,670.00 |
| Sep 30, 2023 | 1,000.00 |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 895.00 |
| Mar 31, 2023 | 895.00 |
| Dec 31, 2022 | 1,343.00 |
| Dec 31, 2022 | 1,343.00 |
| Sep 30, 2022 | 1,200.00 |
| Sep 30, 2022 | 1,200.00 |
| Jun 30, 2022 | 1,200.00 |
| Jun 30, 2022 | 1,200.00 |
| Mar 31, 2022 | 1,353.00 |
| Mar 31, 2022 | 1,353.00 |